Spinal prostaglandin E receptors of the EP2 subtype and the glycine receptor α3 subunit, which mediate central inflammatory hyperalgesia, do not contribute to pain after peripheral nerve injury or formalin injection

Pain

Volumn 126, Issue 1-3, 2006, Pages 46-53

  Hösl, Katharina ^a   Reinold, Heiko ^a   Harvey, Robert J ^b   Müller, Ulrike ^c,d   Narumiya, Shuh ^e   Zeilhofer, Hanns Ulrich ^a,f  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c MAX PLANCK INSTITUTE FOR BRAIN RESEARCH   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e KYOTO UNIVERSITY   (Japan)

^f UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Formalin test; Glycine; Hyperalgesia; Inflammatory pain; Neuropathic pain; PGE2; Prostaglandin E2; Spinal cord

Indexed keywords

FORMALDEHYDE; GLYCINE RECEPTOR; GLYCINE RECEPTOR ALPHA3; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HYPERALGESIA; INFLAMMATION; MOUSE; MOUSE STRAIN; NEUROPATHIC PAIN; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; SENSITIZATION; SPINE; WILD TYPE;

ANIMALS; FORMALDEHYDE; HYPERALGESIA; INFLAMMATION; INJECTIONS; MICE; MICE, KNOCKOUT; NEURALGIA; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; RECEPTORS, GLYCINE; RECEPTORS, PROSTAGLANDIN E; SPINAL CORD;

EID: 33751015432     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2006.06.011     Document Type: Article

References (44)

1. Ahmadi S., Kotalla C., Guhring H., Takeshima H., Pahl A., and Zeilhofer H.U. Modulation of synaptic transmission by nociceptin/orphanin FQ and nocistatin in the spinal cord dorsal horn of mutant mice lacking the nociceptin/orphanin FQ receptor. Mol Pharmacol 59 (2001) 612-618
2. 2 selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons. Nat Neurosci 5 (2002) 34-40
3. Ates M., Hamza M., Seidel K., Kotalla C.E., Ledent C., and Gühring H. Intrathecally applied flurbiprofen produces an endocannabinoid-dependent antinociception in the rat formalin test. Eur J Neurosci 17 (2003) 597-604
4. Baba H., Kohno T., Moore K.A., and Woolf C.J. Direct activation of rat spinal dorsal horn neurons by prostaglandin E2. J Neurosci 21 (2001) 1750-1766
5. Beiche F., Scheuerer S., Brune K., Geisslinger G., and Goppelt-Struebe M. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett 390 (1996) 165-169
6. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
7. Broom D.C., Samad T.A., Kohno T., Tegeder I., Geisslinger G., and Woolf C.J. Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain. Neuroscience 124 (2004) 891-900
8. Coull J.A., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438 (2005) 1017-1021
9. Coull J.A., Boudreau D., Bachand K., Prescott S.A., Nault F., Sik A., et al. Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 424 (2003) 938-942
10. Depner U.B., Reinscheid R.K., Takeshima H., Brune K., and Zeilhofer H.U. Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor. Eur J Neurosci 17 (2003) 2381-2387
11. Dirig D.M., Konin G.P., Isakson P.C., and Yaksh T.L. Effect of spinal cyclooxygenase inhibitors in rat using the formalin test and in vitro prostaglandin E2 release. Eur J Pharmacol 331 (1997) 155-160
12. Donaldson L.F., Humphrey P.S., Oldfield S., Giblett S., and Grubb B.D. Expression and regulation of prostaglandin E receptor subtype mRNAs in rat sensory ganglia and spinal cord in response to peripheral inflammation. Prostaglandins Other Lipid Mediat 63 (2001) 109-122
13. Dubuisson D., and Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4 (1977) 161-174
14. Euchenhofer C., Maihöfner C., Brune K., Tegeder I., and Geisslinger G. Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat. Neurosci Lett 248 (1998) 25-28
15. 2 synthase-1. J Biol Chem 279 (2004) 24866-24872
16. Gühring H., Hamza M., Sergejeva M., Ates M., Kotalla C.E., Ledent C., et al. A role for endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol 454 (2002) 153-163
17. 2-mediated inflammatory pain sensitization. Science 304 (2004) 884-887
18. Hefferan M.P., Carter P., Haley M., and Loomis C.W. Spinal nerve injury activates prostaglandin synthesis in the spinal cord that contributes to early maintenance of tactile allodynia. Pain 101 (2003) 139-147
19. Hefferan M.P., O'Rielly D.D., and Loomis C.W. Inhibition of spinal prostaglandin synthesis early after L5/L6 nerve ligation prevents the development of prostaglandin-dependent and prostaglandin-independent allodynia in the rat. Anesthesiology 99 (2003) 1180-1188
20. Hizaki H., Segi E., Sugimoto Y., Hirose M., Saji T., Ushikubi F., et al. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP2. Proc Natl Acad Sci USA 96 (1999) 10501-10506
21. Kim J., and Alger B.E. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7 (2004) 697-698
22. Kozak K.R., Rowlinson S.W., and Marnett L.J. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J Biol Chem 275 (2000) 33744-33749
23. Lindenlaub T., and Sommer C. Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol (Berl) 105 (2003) 593-602
24. Ma W., and Eisenach J.C. Cyclooxygenase 2 in infiltrating inflammatory cells in injured nerve is universally up-regulated following various types of peripheral nerve injury. Neuroscience 121 (2003) 691-704
25. 2 EP receptors are up-regulated in injured nerve following partial sciatic nerve ligation. Exp Neurol 183 (2003) 581-592
26. Malmberg A.B., and Yaksh T.L. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 263 (1992) 136-146
27. + currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones. Br J Pharmacol 145 (2005) 503-513
28. Minami T., Nakano H., Kobayashi T., Sugimoto Y., Ushikubi F., Ichikawa A., et al. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Br J Pharmacol 133 (2001) 438-444
29. Minami T., Okuda-Ashitaka E., Hori Y., Sakuma S., Sugimoto T., Sakimura K., et al. Involvement of primary afferent C-fibres in touch-evoked pain (allodynia) induced by prostaglandin E2. Eur J Neurosci 11 (1999) 1849-1856
30. Moore K.A., Kohno T., Karchewski L.A., Scholz J., Baba H., and Woolf C.J. Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 22 (2002) 6724-6731
31. 2 stimulates glutamate release from synaptosomes of rat spinal cord. Neurosci Lett 196 (1995) 57-60
32. Reinold H., Ahmadi S., Depner U.B., Layh B., Heindl C., Hamza M., et al. Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest 115 (2005) 673-679
33. O'Rielly D.D., and Loomis C.W. Increased expression of cyclooxygenase and nitric oxide isoforms, and exaggerated sensitivity to prostaglandin E2, in the rat lumbar spinal cord 3 days after L5-L6 spinal nerve ligation. Anesthesiology 104 (2006) 328-337
34. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410 (2001) 471-475
35. Samad T.A., Sapirstein A., and Woolf C.J. Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. Trends Mol Med 8 (2002) 390-396
36. Schäfers M., Marziniak M., Sorkin L.S., Yaksh T.L., and Sommer C. Cyclooxygenase inhibition in nerve-injury- and TNF-induced hyperalgesia in the rat. Exp Neurol 185 (2004) 160-168
37. Southall M.D., and Vasko M.R. Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons. J Biol Chem 276 (2001) 16083-16091
38. 2 release in the spinal cord. J Neurochem 79 (2001) 777-786
39. de Vry J., Kuhl E., Franken-Kunkel P., and Eckel G. Pharmacological characterization of the chronic constriction injury model of neuropathic pain. Eur J Pharmacol 491 (2004) 137-148
40. Woolf C.J. Evidence for a central component of post-injury pain hypersensitivity. Nature 306 (1983) 686-688
41. Yu M., Ives D., and Ramesha C.S. Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem 272 (1997) 21181-21186
42. Zeilhofer H.U. Synaptic modulation in pain pathways. Rev Physiol Biochem Pharmacol 155 (2005) 73-100
43. Zeilhofer H.U. The glycinergic control of spinal pain processing. Cell Mol Life Sci 62 (2005) 2027-2035
44. Zhu X., and Eisenach J.C. Cyclooxygenase-1 in the spinal cord is altered after peripheral nerve injury. Anesthesiology 99 (2000) 1175-1179